Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
DCGI gives EUA nod to SII’s Covovax for 12-17 years’ age group
It is the fourth vaccine to receive the regulator's nod for use among those below 18 years
Dr Reddy’s plans ‘business continuity’ in Russia
The company, however, declined to say if it would raise or scale back investments in Russia, which accounted for more than eight…
Biological E seeks EUA for Corbevax for children in five-12 age group
Corbevax is India's first indigenously developed Receptor Binding Domain (RBD) protein sub-unit vaccine against COVID-19
WHO identifies falsified DESREM remdesivir injection
The genuine manufacturer of DESREM, Mylan Laboratories, has confirmed that the products identified are falsified
Cabinet approves establishment of WHO Global Centre for Traditional Medicine in India
The WHO GCTM will be established in Jamnagar under the Ministry of AYUSH. This would be the first and only global outposted centre…
NIH launches trial to study allergic reactions to COVID-19 mRNA vaccine
The trial is seeking participants who experienced a mild or moderate systemic allergic reaction following the first dose of either…
MSB Docs wins multiple pharma and CRO clients for digital smart document solutions
Clients include organisations from the USA, UK, Argentina, Japan and Canada
Setting the quality agenda from the boardroom
Dilip Surana, CMD, Micro Labs and his leadership team recount how early brushes with regulatory censure helped future-proofed…
Venus Remedies wins WHO GDP certification for quality services across entire supply chain
SGS awarded the WHO GDP certification to Venus Remedies following an elaborate audit
Mandatory QR codes on APIs: Benefit or burden?
Reportedly, 20 per cent of the medicines that are manufactured in India are counterfeit. As per a government report, three per…